A nominee for the Food and Drug Administration faced sharp questioning from senators over contentious issues like vaccine policies and abortion-related regulations, offering only vague responses to pressing concerns. Lawmakers pressed for clarity on how the agency would handle politically divisive public health decisions under new leadership. The hearing highlighted tensions between scientific authority and political expectations as the FDA prepares for potential shifts in oversight. Critics and supporters alike will scrutinize whether the nominee can balance independence with accountability in high-stakes health decisions.
Click in for more news from The Hill {beacon} Healthcare Healthcare The Big Story FDA pick sidesteps tough questions Dr. Heidi Overton, President Donald Trump’s pick to lead the Food and Drug Administration (FDA), walked a fine line Thursday on vaccines and abortion, largely dodging difficult questions from senators. © Greg Nash During the...
